rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1998-5-1
|
pubmed:abstractText |
Many tumors with neuroendocrine characteristics express high amounts of somatostatin receptors that enable in vivo imaging with [(111)In-DTPA-D-Phe1]-octreotide. In this study, we have analyzed the feasibility in detecting and characterizing thymic masses by somatostatin receptor scintigraphy (SRS).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
634-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9544670-Adolescent,
pubmed-meshheading:9544670-Adult,
pubmed-meshheading:9544670-Aged,
pubmed-meshheading:9544670-Carcinoid Tumor,
pubmed-meshheading:9544670-Carcinoma,
pubmed-meshheading:9544670-Diagnosis, Differential,
pubmed-meshheading:9544670-Female,
pubmed-meshheading:9544670-Humans,
pubmed-meshheading:9544670-Iodine Radioisotopes,
pubmed-meshheading:9544670-Magnetic Resonance Imaging,
pubmed-meshheading:9544670-Male,
pubmed-meshheading:9544670-Middle Aged,
pubmed-meshheading:9544670-Octreotide,
pubmed-meshheading:9544670-Pentetic Acid,
pubmed-meshheading:9544670-Radiopharmaceuticals,
pubmed-meshheading:9544670-Thymoma,
pubmed-meshheading:9544670-Thymus Hyperplasia,
pubmed-meshheading:9544670-Thymus Neoplasms,
pubmed-meshheading:9544670-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:9544670-Tomography, X-Ray Computed
|
pubmed:year |
1998
|
pubmed:articleTitle |
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
|
pubmed:affiliation |
Department of Nuclear Medicine National Cancer Institute, Fondazione G. Pascale, Naples, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|